278
Views
57
CrossRef citations to date
0
Altmetric
Original Research

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

, , , , , , , , & show all
Pages 29-36 | Published online: 08 Jan 2016

References

  • MarquesSCOliveiraCROuteiroTFPereiraCMAlzheimer’s disease: the quest to understand complexityJ Alzheimers Dis201021237338320555132
  • MarquesSCOliveiraCRPereiraCMOuteiroTFEpigenetics in neurodegeneration: a new layer of complexityProg Neuropsychopharmacol Biol Psychiatry201135234835520736041
  • MancusoCBatesTEButterfieldDANatural antioxidants in Alzheimer’s diseaseExpert Opin Investig Drugs2007161219211931
  • ColeGMLimGPYangFPrevention of Alzheimer’s disease: omega-3 fatty acid and phenolic anti-oxidant interventionsNeurobiol Aging200526Suppl 113313616266772
  • RossiLMazzitelliSArcielloMCapoCRRotilioGBenefits from dietary polyphenols for brain aging and Alzheimer’s diseaseNeurochem Res200833122390240018415677
  • ThomasPWangYJZhongJHGrape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer’s diseaseMutat Res20096611–2253419027755
  • HendersonSTPoirierJPharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer’s disease; a randomized, double-blind, placebo-controlled studyBMC Med Genet20111213721992747
  • HendersonSTKetone bodies as a therapeutic for Alzheimer’s diseaseNeurotherapeutics20085347048018625458
  • RomanMWAxona (Accera, Inc): a new medical food therapy for persons with Alzheimer’s diseaseIssues Ment Health Nurs201031643543620450347
  • ScheltensPKamphuisPJVerheyFREfficacy of a medical food in mild Alzheimer’s disease: a randomized, controlled trialAlzheimers Dement201061110.e1120129316
  • ThaipisuttikulPGalvinJEUse of medical foods and nutritional approaches in the treatment of Alzheimer’s diseaseClin Pract (Lond)20129219920923362453
  • ReitzCBrayneCMayeuxREpidemiology of Alzheimer diseaseNat Rev Neurol20117313715221304480
  • SmallGWMazziottaJCCollinsMTApolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer diseaseJAMA1995273129429477884953
  • SmallGWLa RueAKomoSKaplanAMandelkernMAPredictors of cognitive change in middle-aged and older adults with memory lossAm J Psychiatry199515212175717648526242
  • SmallGWKuhlDERiegeWHCerebral glucose metabolic patterns in Alzheimer’s disease. Effect of gender and age at dementia onsetArch Gen Psychiatry19894665275322730277
  • HendersonSTVogelJLBarrLJGarvinFJonesJJCostantiniLCStudy of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trialNutr Metab (Lond)200963119664276
  • RegerMAHendersonSTHaleCEffects of β-hydroxybutyrate on cognition in memory-impaired adultsNeurobiol Aging200425331131415123336
  • FolsteinMFFolsteinSEMcHughPR“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
  • McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEMClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology19843479399446610841
  • LewisSJHeatonKWStool form scale as a useful guide to intestinal transit timeScand J Gastroenterol19973299209249299672
  • MohsRCRosenWGDavisKLThe Alzheimer’s disease assessment scale: an instrument for assessing treatment efficacyPsychopharmacol Bull19831934484506635122
  • WenhamPRPriceWHBlandellGApolipoprotein E genotyping by one-stage PCRLancet19913378750115811591674030
  • KuboMHataJDoiYTanizakiYIidaMKiyoharaYSecular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese populationCirculation2008118252672267819106389
  • St-OngeMPBosargeAGoreeLLDarnellBMedium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oilJ Am Coll Nutr200827554755218845704
  • OwenOEMorganAPKempHGSullivanJMHerreraMGCahillGFJrBrain metabolism during fastingJ Clin Invest19674610158915956061736
  • HasselbalchSGMadsenPLHagemanLPChanges in cerebral blood flow and carbohydrate metabolism during acute hyperketonemiaAm J Physiol19962705 Pt 1E746E7518967461
  • CunnaneSNugentSRoyMBrain fuel metabolism, aging, and Alzheimer’s diseaseNutrition201127132021035308
  • Gomez-IslaTWestHLRebeckGWClinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer’s diseaseAnn Neurol199639162708572669
  • HostageCARoy ChoudhuryKDoraiswamyPMPetrellaJRDissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer’s diseasePLoS One201382e5448323405083